U.S. markets closed

Omnicell, Inc. (OMCL)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
29.23-0.01 (-0.03%)
Al cierre: 04:00PM EDT
29.20 -0.03 (-0.10%)
Fuera de horario: 07:42PM EDT

Omnicell, Inc.

4220 North Freeway
Suite 301
Fort Worth, TX 76137
United States
877 415 9990
https://www.omnicell.com

Sector(es)Healthcare
IndustriaHealth Information Services
Empleados a tiempo completo3,650

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Randall A. LippsFounder, Executive Chairman, President & CEO1.2M83.72k1957
Mr. Corey J. ManleyExecutive VP and Chief Legal & Administrative Officer416.02kN/D1978
Mr. Nchacha EttaExecutive VP & CFON/DN/D1972
Ms. Minoo MortazaviSenior Vice President of Global OperationsN/DN/DN/D
Mr. Brian H. NuttVP, Chief Accounting Officer & Corporate ControllerN/DN/D1970
Mr. Giri ChodavarapuSenior VP & Chief Information OfficerN/DN/DN/D
Ms. Kathleen NemethSenior Vice President of Investor RelationsN/DN/DN/D
Mr. Maximo RochaSenior VP & Chief People OfficerN/DN/DN/D
Mr. Joseph Brian SpearsExecutive AdviserN/DN/D1960
Ms. Sara DalmassoSenior VP & GM of InternationalN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Gestión corporativa

La calificación ISS Governance QuickScore de Omnicell, Inc. a partir del 1 de marzo de 2024 es 4. Las puntuaciones principales son Auditoría: 1; Junta: 6; Derechos del accionista: 7; Compensación: 3.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.